misonidazole

misonidazole

A hypoxic-cell radiosensitising agent administered to patients before administering radiation therapy to increase the cancer kill rate.
Mentioned in ?
References in periodicals archive ?
Devi, "Modification of radiation-induced chromosome damage and micronucleus induction in mouse bone marrow by misonidazole and hyperthermia," Acta Oncologica, vol.
The EORTC randomized trial on three fractions per day and misonidazole in advanced head and neck cancer: prognostic factors.
Table 1: PET agents used for myocardial imaging Radionuclide Half-life Radiopharmaceutical Application Rb-82 75 sec Rubidium Chloride MBF N-13 * 10 min Ammonia MBF O-15 * 2 min Water MBF F-18 110 min Fluorodeoxyglucose Glucose metabolism Misonidazole Hypoxia FHTA Fatty acid uptake C-11 * 20 min Acetate Oxygen metabolism Palmitate Fatty acid metabolism Commercially available (italics), Require onsite or nearby cyclotron (*).
Interventions evaluated were: acyclovir, allopurinol mouthrinse, aloe vera, antibiotic pastille or paste, benzydamine, beta carotene, calcium phosphate, camomile, Chinese medicine, chlorhexidine, etoposide, folinic acid, glutamine, granulocyte/macrophage colony-stimulating factor (GM-CSF), histamine gel, honey, hydrolytic enzymes, ice chips, iseganan, keratinocyte GF, misonidazole, pilocarpine, pentoxifylline, povidone, prednisone, propantheline anticholinergic, prostaglandin, sucralfate, systemic antibiotic clarithromycin, traumeel, zinc sulphate.